Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Salesforce

Intel

NIKE

The market has declined, but these stocks have performed much worse.

Should You Buy the Dow Jones' 4 Worst-Performing 2022 Stocks?

Resist the temptation to step into the market's most beaten-down names. They're deeply discounted for a reason.

Is It Time to Buy the Dow Jones' 4 Worst-Performing August Stocks?

PepsiCo

Walmart

Should investors be watching these consumer staples stocks during market uncertainties?

3 Consumer Staples Stocks For September 2022

Walgreens Boots Alliance has completed its $330 million majority stake investment in post acute and home care company CareCentrix.

Walgreens Finalizes CareCentrix Home Care Investment As Rivals Bid On Signify Health

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced it has completed its previously announced majority share acquisition of CareCentrix, Inc.—the leading independent home-centered platform that coordinates care to the home for health plans, patients and providers. The majority investment in CareCentrix accelerates Walgreens Health's capabilities in delivering quality healthcare across a spectrum of settings including primary care, specialty pharmacy ca

Walgreens Boots Alliance Completes Majority Share Acquisition of CareCentrix

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that Alethia Jackson has been named senior vice president, ESG (environmental, social and governance) and chief DEI (diversity, equity and inclusion) officer for the U.S. Jackson most recently served as vice president, federal government relations for Walgreens, and will assume her new role Oct. 1. She will report to Holly May, executive vice president and global chief human resources officer, Walgree

Walgreens Boots Alliance Names Alethia Jackson Senior Vice President, ESG and Chief DEI Officer

Blackstone Group

Verizon

Verizon Communications Inc 5.9 % Notes 2014-15.2.54 Sr

Dividend yields over 5% are a great reason to buy these stocks.

3 Cheap Dividend Stocks to Buy Today

M.D.C. Holdings

Western Union

Fidelity National Financial

When most people reach the age of 50, they start thinking about retirement. At this age, you need a strategy in place about housing, working and income before retiring.

5 Income Stocks for Retirees

Altria

These income-generating giants are a bargain at these prices.

2 Great Dividend Stocks You Can Buy for Less Than $50

Target

Payout growth is the key to success in consumer dividend stocks.

Want $1,000 in Passive Income? 2 High-Dividend Stocks to Snap Up.

Alliance Resource Partners

Enterprise Products Partners

These passive-income powerhouses, with yields ranging from 5% to 7%, can make patient investors a lot richer over the next four years.

Nasdaq Bear Market: 3 High-Yield Dividend Stocks That Can Double Your Money by 2026

WBA's Q3 FY ‘22 earnings announcement was a disaster for the stock, sending shares below $37, on top of an already lousy year. However, context offers that the core business performed well in Q3 and Walgreens Health is on track to achieve its CY ‘22 targets.

Walgreens: Sticking It Out For $50+/Share

Walgreens faces legal challenges as rising costs eat into profit margins. Is Walgreens stock a buy?

Is WBA Stock A Buy Or Sell After Pivotal Court Ruling In Opioids Case?

Walgreens Boots Alliance Inc (NASDAQ: WBA) is down 5.0% on Thursday after a U.S. federal judge held the chain of retail pharmacies accountable for its part in fuelling the opioid crisis in Lake and Trumbull counties.

Pro: ‘I'd stay far away from Walgreens Boots Alliance'

CVS Health

Walmart, CVS, and Walgreens must pay a combined $650.6 million to two Ohio counties for damages related to the opioid crisis, a federal judge ruled Wednesday.

Ohio judge rules Walmart, CVS, and Walgreens must pay a combined $650.6 million for damages related to opioid crisis

CLEVELAND — A federal judge in Cleveland awarded $650 million in damages Wednesday to two Ohio counties that won a landmark lawsuit against national pharmacy chains CVS, Walgreens and Walmart, claiming the way they distributed opioids to customers caused severe harm to communities and created a public nuisance.

CVS, Walmart, Walgreens owe two Ohio counties $650 million in landmark opioid lawsuit

Dow member Walgreens Boots Alliance Inc (NYSE:WBA) is looking to snap a five-day win streak ahead of tomorrow' ex-dividend date.

Walgreens Boots Alliance Could Extend Today's Slide

CVS, Walgreens and Walmart must pay damages to two Ohio counties for oversupplying pills that ended up on black market

US pharmacies ordered to pay $650.6m for role in opioids crisis

This can partly be attributed to oversold conditions for WBA and a rebound in the broader markets, with the S&P 500 index rising 13% over the same period.

Is A Fall Imminent For Walgreens Stock After An 8% Rise In A Month?

Air Products and Chemicals

Franklin Resources

Community Trust Bancorp

Emerson Electric

Johnson & Johnson

Coca-Cola

Leggett & Platt

Medtronic

National Fuel Gas

Northwest Natural Gas

Old Republic International

Stanley Black & Decker

Telephone and Data Systems

Universal Corp

Exxon Mobil

DRIP Investing lists over 800 stocks that have annually increased dividends for 5 years or more. As of July, 62 stocks have hiked their dividends annually 40 years or more. Parsed from 129 Champions, utilizing YCharts data as of 8/15/22, those 62 select-dividend stocks ranged 0.87% to 5.95% in annual yield, and ranged -17.74% to 31.143% in analyst 1-yr price.

Buy 6 August 40+ Year Dividend Growers

Pharmacists are in such high demand that Walgreens is offering a hefty signing bonus of up to $75,000.

Walgreens is offering up to $75,000 to recruit pharmacists amid shortage

Are you interested in a signing bonus the size of a salary? If you are a pharmacist, this could be your opportunity.

Want a big signing bonus? Walgreens is offering $75,000 to recruit pharmacists

Pharmacists are in such high demand that Walgreens is dangling lucrative signing bonuses to fill open positions.

Walgreens is paying signing bonuses up to $75,000 to lure pharmacists

In a 112-page opinion, US District Judge Charles Breyer wrote Walgreens failed to perform "adequate due diligence" in reviewing suspicious orders.

Federal judge rules Walgreens advanced San Francisco's opioid epidemic by dispensing 'hundreds of thousands of red flag prescriptions'

Pharmacies across the US have struggled with staffing throughout the pandemic as workers juggled prescriptions, COVID testing, and vaccines.

News for Walgreens Stock (WBA)